IIA
ANIK icon

IPG Investment Advisors’s Anika Therapeutics ANIK Stock Holding History

IPG Investment Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7,500
Closed -$347K – 109
2014
Q2 		$347K Buy
+7,500
New +$334K 0.15% 71

Other funds holding ANIK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Gotham Asset Management
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

IPG Investment Advisors's ANIK Position: Q3 2014 in Review

IPG Investment Advisors sold out of Anika Therapeutics (ANIK) in Q3 2014, closing a stake of 7,500 shares — an estimated $347K sold.

IPG Investment Advisors first reported a position in ANIK in Q2 2014 and held it in 1 quarter. The position peaked at $347K in Q2 2014. 153 funds tracked by Wall St. Rank hold ANIK as of Q3 2014.

  • IPG Investment Advisors reported no remaining Anika Therapeutics position as of Q3 2014 after selling out during the quarter.
  • IPG Investment Advisors sold 7,500 Anika Therapeutics shares in Q3 2014, an estimated $347K.
  • IPG Investment Advisors first reported a position in Anika Therapeutics in Q2 2014 and held it in 1 quarter.
  • IPG Investment Advisors's Anika Therapeutics position peaked at $347K in Q2 2014.
  • 153 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2014.

Based on IPG Investment Advisors's 13F filing for Q3 2014, filed 10 Nov 2014.